local
New kind of flu shot is on the way as the FDA approves Moderna’s mRNA-based vaccine
Summary by The Odessa Editorial Desk Associated Press , as published by Odessa American (oaoa.com)
· August 6, 2026
· 1 min read
Photo: Odessa American (oaoa.com) · view original
Story provenance No corrections
Summary created by The Odessa Editorial Desk — automated, rule-governed Byline on source page Associated Press, as published by Odessa American (oaoa.com) Original story Read at the source Source published Aug 6, 2026 Indexed here Aug 6, 2026 AI assistance Automated summary drawn from the source’s own published text Prepublication human review No — editorial rules, flagged-item review, and published samples
Every story comes with a passport. How we work · Corrections log
Key takeaway This vaccine, made by Moderna, uses mRNA technology, which was also used to develop COVID-19 vaccines.
A new flu vaccine has been approved by the Food and Drug Administration for adults 50 and older. This vaccine, made by Moderna, uses mRNA technology, which was also used to develop COVID-19 vaccines. The vaccine, named mFlusiva, is expected to be available soon at select retailers.
Other flu shots have already started arriving at pharmacies in preparation for the fall vaccination season. Further details about the new vaccine and its availability in Odessa can be found through the Odessa American. The approval of this new vaccine comes as flu season approaches, a time when older adults are particularly vulnerable to influenza.
Why this matters
Local news anchors readers in their community — the people, places, and decisions that shape day-to-day life. The Odessa covers these stories because national outlets often won't.
About this story
As published by Odessa American (oaoa.com) . The Odessa surfaces reporting from trusted publishers and adds local editorial context so readers can quickly understand what a story means for their community. We attribute every source, link to the original report, and follow a documented editorial standards policy. To understand how stories are selected and reviewed, read our about page .
For the complete original report, visit Odessa American (oaoa.com) . Have a tip or correction? Contact our newsroom .
Category: local Published: August 6, 2026 Source: Odessa American (oaoa.com) Reading time: 1 min
Frequently asked about this story
What is this story about? A new flu vaccine has been approved by the Food and Drug Administration for adults 50 and older. This vaccine, made by Moderna, uses mRNA technology, which was also used to develop COVID-19 vaccines…
When was this published? This article was first published on August 6, 2026 by Odessa American (oaoa.com) and curated for The Odessa readers.
Who reported this story? This story was reported by Associated Press at Odessa American (oaoa.com). To learn more about how The Odessa selects and reviews stories, see our editorial standards .
Where can I find related coverage? See more local coverage from The Odessa, or browse our daily briefing and topic hubs .
← Back to all news
More local →
Today’s briefing
Subscribe to newsletter
